![Samuel Agresta](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Samuel Agresta
Plus aucun poste en cours
Fortune : - $ au 31/05/2026
Profil
Samuel Agresta is Chief Medical Officer at OnKure Therapeutics, Inc. since 2024.
Former positions include Senior Medical Director at Genentech, Inc. from 2007 to 2010; Senior Medical Director at Merrimack Pharmaceuticals, Inc. from 2010 to 2011; Director at Infinity Pharmaceuticals, Inc. from 2019 to 2023; Associate Medical Director at H.
Lee Moffitt Cancer Center & Research Institute, Inc. from 2004 to 2010; Vice President & Head-Clinical Development at Agios Pharmaceuticals, Inc. from 2011 to 2018; and Chief Medical Officer at Foghorn Therapeutics, Inc. from 2019 to 2023.
Education includes graduate studies at the University of South Florida, an undergraduate degree from Georgetown University in 1994, a doctorate from Tulane University School of Medicine, and graduate studies at Tulane University School of Public Health & Tropical Medicine.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
-.--% | 01/04/2026 | 0 ( -.--% ) | - $ | 31/05/2026 |
Postes actifs de Samuel Agresta
| Sociétés | Poste | Début |
|---|
Anciens postes connus de Samuel Agresta
| Sociétés | Poste | Fin |
|---|---|---|
| FOGHORN THERAPEUTICS INC. | Directeur Technique/Scientifique/R&D | 11/09/2023 |
| INFINITY PHARMACEUTICALS, INC. | Directeur Technique/Scientifique/R&D | 16/10/2019 |
| AGIOS PHARMACEUTICALS, INC. | Directeur Technique/Scientifique/R&D | 01/08/2018 |
| MERRIMACK PHARMACEUTICALS | Directeur Technique/Scientifique/R&D | 01/12/2011 |
Genentech, Inc.
 Genentech, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that develops medicines for cancer peoples | Directeur Technique/Scientifique/R&D | 01/12/2010 |
Formation de Samuel Agresta
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
90
Relations au 1er degré
11
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 11 |
|---|---|
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that develops medicines for cancer peoples | Health Technology |
Agios Pharmaceuticals, Inc.
 Agios Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Discovers and develops therapeutics | Health Technology |
OnKure, Inc.
 OnKure, Inc. BiotechnologyHealth Technology Operates as a biopharmaceutical company developing epigenetic therapies for the treatment of cancer | Health Technology |
Merrimack Pharmaceuticals, Inc.
 Merrimack Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Discovers, develops and commercializes drugs for the treatment of immunological & autoimmune diseases and cancer | Health Technology |
Infinity Pharmaceuticals, Inc.
 Infinity Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage biopharmaceutical company that develops medicines for the treatment of cancer | Health Technology |
University of South Florida
 University of South Florida Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Georgetown University
 Georgetown University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
H. Lee Moffitt Cancer Center & Research Institute, Inc.
 H. Lee Moffitt Cancer Center & Research Institute, Inc. Miscellaneous Commercial ServicesCommercial Services Provides research & contributions to clinical trials, prevention and cancer control | Commercial Services |
Tulane University School of Medicine
 Tulane University School of Medicine Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Tulane University School of Public Health & Tropical Medicine
 Tulane University School of Public Health & Tropical Medicine Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Foghorn Therapeutics, Inc.
 Foghorn Therapeutics, Inc. BiotechnologyHealth Technology Discovers and develops novel drugs to treat cancer and other serious medical disorders | Health Technology |
